Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

What’s new for 2018?

See full agenda below, or click on one of the sessions at the top of the page to go straight to that part of the agenda. You can also download the agenda if you would rather save a copy to your computer - download it here.


Keynote Sessions
08:30 - 09:00
The empowered patient: Building a partnership of trust
  • Recognize the growing need to better understand life with disease, and the role of the patient and caregiver in providing vital insights across the entire drug lifecycle
  • Discover ways to operationalize patient engagement, implementing a robust framework which works across all functions (using Astellas examples).
  • Identify authentic patient communications insights – and understand when and where a closer relationship can help improve a patient’s healthcare experience

Astellas Jim Robinson President U.S. Astellas

09:00 - 09:30
How your company can bring humanity back to healthcare
  • Why we must recognize the danger of putting a premium on systems, data and processes, and neglecting human relationships
  • Has pharma lost its humanity? Avoid the endless restructuring of our commercial model and bring back partnerships with authenticity
  • How to translate humanity into the physician’s office: use category management and medical education to build credibility and establish long-term customers. Witness how Ferring are achieving this in the fertility domain.

Ferring Holdings Inc Paul Navarre CEO Ferring Holdings Inc

09:30 - 10:00
Panel: ‘Value’: focus on the common objectives amidst the chaos
  • Develop the shift to value-based care and explore its potential to set an acceptable ‘new normal’ for drug pricing
  • Discover how best to demonstrate true value of your drug when interacting with a complex array of stakeholders
  • Understand pharma’s unique position in the delivery of healthcare to understand which partnerships and collaborations are required, moving forwards

Lilly Oncology Sue Mahony Senior Vice President & President Lilly Oncology

Novartis Fabrice Chouraqui President, U.S. Novartis

PhRMA Stephen Ubl President & CEO PhRMA

09:30 - 10:00
Digital is not only here to stay, it’s the new lifeblood of your organization
  • Discover the role digital communication will play in bringing your drug to markets – beyond simple messaging – and how it is redefining your customer relationships
  • Envisage the next level of patient experience that digital can provide, whilst ensuring deeper feedback and insights for your organization
  • Highlight the potential digital monitoring and sensors can play in improving adherence rates and diagnostics, further supporting the relationship between HCPs and patients

Teva Markus Leyck Dieken Senior Vice President, Global Head, CNS Teva

09:30 - 10:00
Panel: Big data, bigger opportunity
  • Envisage the monumental long-term effect of real world data informing customers as well as ourselves; particularly with regard to drug discovery, patient access and commercialization
  • Understand the trajectory and adoption of sensors to collect real-time patient insight and their future implications
  • Realize the potential in the analytics of vast quantities of data and where this will influence prescribers, payers, policy makers and other stakeholders

Bayer Dr. Carsten Brunn Head of Pharmaceuticals, Americas Region Bayer

UCB Bharat Tewarie Executive Vice President, Chief Marketing Officer UCB

Additional panellists to be announced in the coming weeks.

Commercial Model Innovation
08:30 - 09:00
Panel. Why patient-centricity is key for any successful business
  • Establish the relationship between business growth and patient focus
  • Explore metrics to reveal the commercial impact of patient-centric initiatives, including performance milestones that can guide line management
  • Expand your business offering to truly service patients and provide support needed for HCPs to deliver the full potential of your product

Novartis Lisa Deschamps Vice President and U.S Head of the Neuroscience Business Unit Novartis

Eisai, Inc. Beyhan Zaim Global Head, Alzheimer's Disease Franchise Eisai, Inc.

Additional panellists to be announced in the coming weeks.

09:00 - 09:30
Gain competitive advantage with a more holistic solution around your product
  • Differentiate your product by building around-the-pill offerings which improve adherence and better address patient needs
  • Address the growing demands of the digitally native customer by co-creating solutions using the process of ‘design thinking’
  • Develop better communication channels in combination with HCPs and patients to ensure your solution is well received and further improves customer loyalty

Sanofi Bozidar Jovicevic Global Head of Digital Medicines Sanofi

End-to-end Customer Experience
08:30 - 09:00
Panel: Optimize customer experience with a flawless end-to-end process
  • Ensure all departments are engaged with the creation of insights and understanding of the customer journey
  • Operationalize delivery of customer solutions with a cross-functional approach
  • Develop KPIs which relate customer experience to commercial results to ensure continued support from senior management

Regeneron Michael Suesserman VP, Marketing Regeneron

Lilly Deb Hussain Senior Director of Marketing, MCE Team Leader Lilly

Additional panellists to be announced in the coming weeks.

09:00 - 09:30
Communication, Connection, Personalization
  • How the development of mobile technology will enhance your ability to create personalized connections and form stronger relationships between patients, HCPS and healthcare organisations alike
  • Understand what the future of health in a mobile world looks like by exploring how pharma companies are taking a more connected and personal approach to communications; creatively building communities and exploring new brand opportunities.

Facebook Health Danielle Salowski Industry Manager Facebook Health

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Healthcare Initiative’ category from the eyeforpharma awards

For the first time ever, the winner of the award that celebrates value and innovation to healthcare and HCPs, will be detailing their initiative on stage. Join this session to:

  • Envisage how a leading pharma company ran an innovative project designed to deliver tangible working and healthcare improvements both in the long and short term
  • Learn how to create a positive impact on your intended customer demonstrating a real understanding of healthcare requirements

Previous winners includes Teva’s AI disruptor ‘Ask Claire’, a virtual assistant to help MS patients

Advances in Multichannel Customer Engagement
08:30 - 09:00
Meet demand: Deliver valuable content, however and whenever customers want it
  • Why evolving customer demands require you to produce even more valuable, on-demand knowledge insights to help HCPs make medical decisions
  • Tailor the delivery of your content to address a range of stakeholders –ensuring you cater to the needs of patients
  • Coordinate your MCM strategy with your sales reps to ensure harmonious communication and further engagement across other channels

Merck Tricia Brown Executive Director, Leader of US Promotion Organization Merck

09:00 - 09:30
Perfecting brand marketing online, at the moments that matter
  • Discover how expectations for health brands has risen due to patients being smarter and more demanding
  • Re-think the way you engage across screens and devices with your video marketing strategy
  • Utilize new models of short and long form video

Moderator: Google David Blair Head of Industry, Healthcare Google

Genuine Patient Partnerships
08:30 - 09:00
Deliver on value: Effectively demonstrate the value of patient engagement
  • Look past traditional ROI metrics to effectively measure and communicate the value of patient support programs
  • Align the needs of your external stakeholders with your internal activities to provide benefit for both your patients and organisation
  • Gain internal alignment on the need for further patient engagement by effectively demonstrating value

Teva Jason Degoes Senior Vice President, Patient Solutions Teva

09:00 - 09:30
Panel: Where is the trust? Strengthen relationships through partnerships and collaborations
  • Establish win-win partnerships with advocacy groups and patient organizations to help support patients and ensure their voice is heard across your entire company
  • Become the go-to trusted source of information, improving your reach to smaller sub-populations of patients and ensuring greater levels of support
  • Best practice examples of how to work with external groups while staying compliant

Patient Power Andrew Schorr Founder Patient Power

Adult Congenital Heart Association Georgia Krehbiel National Director of Development Adult Congenital Heart Association

Additional panellists to be announced in the coming weeks.

09:30 - 10:00
Demonstrate the Impact of the Clinical Educator to drive Adherence
  • Discover how real connections with patients and providers can differentiate your brand
  • Engage Clinical Educators to address unmet patient needs
  • Achieve better outcomes by optimizing your patient support programs

VMS BioMarketing Andrea Heslin Smiley President and Chief Executive Officer VMS BioMarketing

Perfecting Patient Support Programs
08:30 - 09:00
Walking in a patient’s shoes: Building your commercialization approach with the patient in mind
  • Drive a culture change that encourages all team members to understand the needs of patients – a mission critical step for the success of the industry
  • Build greater awareness of what it means to live with a disease and align others – whether policymakers, providers or caregivers – on the struggle of patients
  • Implement a multi-pronged approach that is designed with the patient, rather than the company, in mind

GSK Cheryl Macdiarmid Senior Vice President, Primary Care, U.S. GSK

09:00 - 09:30
Panel: Create the ideal eco-system of patient support that delivers results
  • Create a clear vision for your patient support programs which address unmet needs in a simple and effective way
  • Understand how patients and other stakeholders can co-create programs to ensure user experience and delivery is optimized
  • Measure the success of your program with relevant KPIs and ensure continuous feedback to help perfect future support activities

Eli Lilly Canada Andre Cote Chief Operating Officer Eli Lilly Canada

Colontown Meredith Hardy Patient Advocate Colontown

US Pain Foundation inc. Paul Gileno Founder/President US Pain Foundation inc.

FDA Steve Morin Health Programs Coordinator and Director, FDA Patient Network FDA

09:30 - 10:00
Integrating digital to enhance patient support programs: Micro-moments – provide continuous and relevant support throughout the patient journey
  • Understand how to move from an episodic to a continuous patient support model
  • Learn how to understand each individual’s needs across a patient population
  • Integrate behavioral science and provide personalized support specific to each patient’s circumstance

S3 Connected Health Jim O’Donoghue Vice President S3 Connected Health

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Pharma Collaboration’ category from the eyeforpharma Awards

For the first time ever, the winners of the eyeforpharma Awards will be showcasing their winning initiatives. Join this session to:

  • See the very best examples of pharma companies collaborating for a common goal: value to patients and healthcare, using lateral thinking to redefine what’s possible in our industry
  • Identify how you can deliver a new proposition to customers and healthcare systems, creating real innovations, through partnerships

Previous winners include “Moving Mountains for Multiple Myeloma” a partnership between Takeda Oncology, the MMRF and Cure Media.

Talent, Diversity and Reputation
08:30 - 09:00
Panel: Celebrate and nucleate the rock stars of healthcare: How to guarantee talent and diversity
  • Turn your great science, genuine innovation and social mission into a story which appeals to a new generation of incoming talent
  • Identify the future skills and capabilities required by your organization and ensure your recruitment process matches your growing needs
  • Find ways to motivate and satisfy your employees to encourage retention and safeguard the next generation of leaders

Takeda Pharmaceuticals Elena Cant Vice President, Head of Global Commercial, Vaccine Business Unit Takeda Pharmaceuticals

Merck Celeste Warren Vice President, Human Resources and Global Diversity & Inclusion Center of Excellence Merck

Data Capabilities and Analytics
08:30 - 09:00
Unleash the power of data: Optimizing commercial performance though data and analytics
  • Drive competitive advantages through data-driven decision-making based on customer insights and analytics
  • Improve performance of commercial activities through the right metrics, actionable reporting and holistic processes
  • Manage data gaps and data imperfections

Bristol-Myers Squibb Tatiana Simonelli Head of Business Insights & Analytics International Markets Bristol-Myers Squibb

09:00 - 09:30
The power of data to optimize your multichannel strategy
  • Take an innovative approach to measure the success of your MCM, including new measurables to assess the overall impact of your strategy and go beyond individual metrics
  • Benchmark touchpoints along the customer journey, from a combination of channels, which clearly highlight overall performance and red flag areas that need improvement
  • Identify patterns in customer behavior and ensure flexibility in your multichannel model to adapt to new analysis

Bayer Peter Barschdorff Vice President, Business Insights: Innovation Strategy Bayer

External Innovation & Collaboration
08:30 - 09:00
The power of digital Health: Transform opportunity into genuine patient benefit
  • Take advantage of the vast opportunities in digital health by partnering with digital health companies across the healthcare ecosystem
  • Discover what Takeda have learnt from digital health companies, and how they have applied this agile and innovative thinking to their approach
  • Identify where pharma has the greatest opportunity to impact patient’s lives and why must be align as an industry to focus our efforts

Takeda Pharmaceuticals Nicole Mowad Nassar Vice President & Head of U.S. Business Operations & External Partnerships Takeda Pharmaceuticals

09:00 - 09:30
Reach new levels of value: Advancing care in cardiology through partnerships
  • Discover how BMS increased the effective diagnosis of cardio-related diseases through partnerships with governments, payers, data providers and tech
  • Lay the groundwork for effective, long term partnerships and help establish pharma’s role in the larger healthcare ecosystem
  • Navigate reimbursement issues using data and analysis required to prove the value of your services and solutions

Bristol-Myers Squibb Terri Young Worldwide General Manager, Cardiology Bristol-Myers Squibb

09:30 - 10:00
Panel: Is the future of healthcare on your wrist? Optimizing wearables now, not in the future
  • Explore the vast opportunities possible with mobile data recording devises and establish the role wearables can play in your healthcare offering
  • Determine the uses of the real-world data collected and how this data can be effectively analyzed as well as understanding the limitations Prepare for the explosion in wearables and IoT devices and ensure you have a robust strategy which moves past the early adoption stage

Nokia Health Alexis Normand Head of B2B Nokia Health

Samsung Jerard Berger Senior Manager, Healthcare Samsung

Novartis Abhimanyu Verma Global Head – Applied Technology Innovation Novartis

GSK Andrew Ploszay Head, Digital Innovation & Strategic Partnerships GSK

09:30 - 10:00
Leading Innovation: The Digital Medicines
  • Discover how Otsuka and Proteus pioneered an innovative alliance to develop Digital Medicines • Identify best practices when uniting the pharma development and business model with digital technology • Envisage how Otsuka’s new digital medicine might help patients manage their illness and share valuable, objective data with HCPs

Proteus Digital Health David O’Reilly Chief Platform Officer Proteus Digital Health

Otsuka America Pharmaceutical, Inc. Andrew Wright VP, Digital Medicine Otsuka America Pharmaceutical, Inc.

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Pharma Collaboration’ category from the eyeforpharma awards

For the first time ever, the winners of the eyeforpharma Awards will be showcasing their winning initiatives. Join this session to:

  • See the very best examples of pharma companies collaborating for a common goal: value to patients and healthcare, using lateral thinking to redefine what’s possible in our industry
  • Identify how you can deliver a new proposition to customers and healthcare systems, creating real innovations, through partnerships
Sell with Purpose: Kickstart your salesforce
08:30 - 09:00
Build customer relations for the future: Replicate the success of your top performing reps
  • Establish the traits of your top performers with a program that moves middle performers from good to great, and introduces newly relevant skills
  • Define the KPIs needed to measure success in a new climate, and reward positive behaviours which improve long-term customer experience
  • Ensure your reps are upskilled for new digital tools and capabilities

Shire Molly Painter Vice President, Sales, Primary Immunodeficiency and Hereditary Angioedema Shire

09:00 - 09:30
Drive sales through greater alignment of drugs to customer value – and a deeper understanding of the patient journey
  • Discover how top performing reps relate to the patient journey when engaging with HCPs
  • Fully express the value of your products with an improved understanding of life with the illness
  • Explore new ways to train, motivate and incentivize reps which focus on patient needs and meeting customer needs

Roche Diabetes Jay Graves Vice President, Sales Roche Diabetes

09:30 - 10:00
Overcome complexity in the U.S market: A better KAM approach
  • Address the growing complexity of stakeholders with a more sophisticated Key Account Management (KAM) formation, identifying unmet need within healthcare systems
  • Embed new capabilities into account teams (including medical and HEOR) to ensure customer needs can be met
  • Adapt to new methods of engagement, ensuring your reps are well equipped to engage with a new generation of HCPs

Horizon Pharma Paul Lazarro Vice President, Primary Care Sales & Key Accounts Horizon Pharma

Keynote Sessions
08:30 - 09:00
The empowered patient: Building a partnership of trust
  • Recognize the growing need to better understand life with disease, and the role of the patient and caregiver in providing vital insights across the entire drug lifecycle
  • Discover ways to operationalize patient engagement, implementing a robust framework which works across all functions (using Astellas examples).
  • Identify authentic patient communications insights – and understand when and where a closer relationship can help improve a patient’s healthcare experience

Astellas Jim Robinson President U.S. Astellas

09:00 - 09:30
How your company can bring humanity back to healthcare
  • Why we must recognize the danger of putting a premium on systems, data and processes, and neglecting human relationships
  • Has pharma lost its humanity? Avoid the endless restructuring of our commercial model and bring back partnerships with authenticity
  • How to translate humanity into the physician’s office: use category management and medical education to build credibility and establish long-term customers. Witness how Ferring are achieving this in the fertility domain.

Ferring Holdings Inc Paul Navarre CEO Ferring Holdings Inc

09:30 - 10:00
Panel: ‘Value’: focus on the common objectives amidst the chaos
  • Develop the shift to value-based care and explore its potential to set an acceptable ‘new normal’ for drug pricing
  • Discover how best to demonstrate true value of your drug when interacting with a complex array of stakeholders
  • Understand pharma’s unique position in the delivery of healthcare to understand which partnerships and collaborations are required, moving forwards

Lilly Oncology Sue Mahony Senior Vice President & President Lilly Oncology

Novartis Fabrice Chouraqui President, U.S. Novartis

PhRMA Stephen Ubl President & CEO PhRMA

09:30 - 10:00
Digital is not only here to stay, it’s the new lifeblood of your organization
  • Discover the role digital communication will play in bringing your drug to markets – beyond simple messaging – and how it is redefining your customer relationships
  • Envisage the next level of patient experience that digital can provide, whilst ensuring deeper feedback and insights for your organization
  • Highlight the potential digital monitoring and sensors can play in improving adherence rates and diagnostics, further supporting the relationship between HCPs and patients

Teva Markus Leyck Dieken Senior Vice President, Global Head, CNS Teva

09:30 - 10:00
Panel: Big data, bigger opportunity
  • Envisage the monumental long-term effect of real world data informing customers as well as ourselves; particularly with regard to drug discovery, patient access and commercialization
  • Understand the trajectory and adoption of sensors to collect real-time patient insight and their future implications
  • Realize the potential in the analytics of vast quantities of data and where this will influence prescribers, payers, policy makers and other stakeholders

Bayer Dr. Carsten Brunn Head of Pharmaceuticals, Americas Region Bayer

UCB Bharat Tewarie Executive Vice President, Chief Marketing Officer UCB

Additional panellists to be announced in the coming weeks.

Commercial Model Innovation
08:30 - 09:00
Panel. Why patient-centricity is key for any successful business
  • Establish the relationship between business growth and patient focus
  • Explore metrics to reveal the commercial impact of patient-centric initiatives, including performance milestones that can guide line management
  • Expand your business offering to truly service patients and provide support needed for HCPs to deliver the full potential of your product

Novartis Lisa Deschamps Vice President and U.S Head of the Neuroscience Business Unit Novartis

Eisai, Inc. Beyhan Zaim Global Head, Alzheimer's Disease Franchise Eisai, Inc.

Additional panellists to be announced in the coming weeks.

09:00 - 09:30
Gain competitive advantage with a more holistic solution around your product
  • Differentiate your product by building around-the-pill offerings which improve adherence and better address patient needs
  • Address the growing demands of the digitally native customer by co-creating solutions using the process of ‘design thinking’
  • Develop better communication channels in combination with HCPs and patients to ensure your solution is well received and further improves customer loyalty

Sanofi Bozidar Jovicevic Global Head of Digital Medicines Sanofi

End-to-end Customer Experience
08:30 - 09:00
Panel: Optimize customer experience with a flawless end-to-end process
  • Ensure all departments are engaged with the creation of insights and understanding of the customer journey
  • Operationalize delivery of customer solutions with a cross-functional approach
  • Develop KPIs which relate customer experience to commercial results to ensure continued support from senior management

Regeneron Michael Suesserman VP, Marketing Regeneron

Lilly Deb Hussain Senior Director of Marketing, MCE Team Leader Lilly

Additional panellists to be announced in the coming weeks.

09:00 - 09:30
Communication, Connection, Personalization
  • How the development of mobile technology will enhance your ability to create personalized connections and form stronger relationships between patients, HCPS and healthcare organisations alike
  • Understand what the future of health in a mobile world looks like by exploring how pharma companies are taking a more connected and personal approach to communications; creatively building communities and exploring new brand opportunities.

Facebook Health Danielle Salowski Industry Manager Facebook Health

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Healthcare Initiative’ category from the eyeforpharma awards

For the first time ever, the winner of the award that celebrates value and innovation to healthcare and HCPs, will be detailing their initiative on stage. Join this session to:

  • Envisage how a leading pharma company ran an innovative project designed to deliver tangible working and healthcare improvements both in the long and short term
  • Learn how to create a positive impact on your intended customer demonstrating a real understanding of healthcare requirements

Previous winners includes Teva’s AI disruptor ‘Ask Claire’, a virtual assistant to help MS patients

Advances in Multichannel Customer Engagement
08:30 - 09:00
Meet demand: Deliver valuable content, however and whenever customers want it
  • Why evolving customer demands require you to produce even more valuable, on-demand knowledge insights to help HCPs make medical decisions
  • Tailor the delivery of your content to address a range of stakeholders –ensuring you cater to the needs of patients
  • Coordinate your MCM strategy with your sales reps to ensure harmonious communication and further engagement across other channels

Merck Tricia Brown Executive Director, Leader of US Promotion Organization Merck

09:00 - 09:30
Perfecting brand marketing online, at the moments that matter
  • Discover how expectations for health brands has risen due to patients being smarter and more demanding
  • Re-think the way you engage across screens and devices with your video marketing strategy
  • Utilize new models of short and long form video

Moderator: Google David Blair Head of Industry, Healthcare Google

Genuine Patient Partnerships
08:30 - 09:00
Deliver on value: Effectively demonstrate the value of patient engagement
  • Look past traditional ROI metrics to effectively measure and communicate the value of patient support programs
  • Align the needs of your external stakeholders with your internal activities to provide benefit for both your patients and organisation
  • Gain internal alignment on the need for further patient engagement by effectively demonstrating value

Teva Jason Degoes Senior Vice President, Patient Solutions Teva

09:00 - 09:30
Panel: Where is the trust? Strengthen relationships through partnerships and collaborations
  • Establish win-win partnerships with advocacy groups and patient organizations to help support patients and ensure their voice is heard across your entire company
  • Become the go-to trusted source of information, improving your reach to smaller sub-populations of patients and ensuring greater levels of support
  • Best practice examples of how to work with external groups while staying compliant

Patient Power Andrew Schorr Founder Patient Power

Adult Congenital Heart Association Georgia Krehbiel National Director of Development Adult Congenital Heart Association

Additional panellists to be announced in the coming weeks.

09:30 - 10:00
Demonstrate the Impact of the Clinical Educator to drive Adherence
  • Discover how real connections with patients and providers can differentiate your brand
  • Engage Clinical Educators to address unmet patient needs
  • Achieve better outcomes by optimizing your patient support programs

VMS BioMarketing Andrea Heslin Smiley President and Chief Executive Officer VMS BioMarketing

Perfecting Patient Support Programs
08:30 - 09:00
Walking in a patient’s shoes: Building your commercialization approach with the patient in mind
  • Drive a culture change that encourages all team members to understand the needs of patients – a mission critical step for the success of the industry
  • Build greater awareness of what it means to live with a disease and align others – whether policymakers, providers or caregivers – on the struggle of patients
  • Implement a multi-pronged approach that is designed with the patient, rather than the company, in mind

GSK Cheryl Macdiarmid Senior Vice President, Primary Care, U.S. GSK

09:00 - 09:30
Panel: Create the ideal eco-system of patient support that delivers results
  • Create a clear vision for your patient support programs which address unmet needs in a simple and effective way
  • Understand how patients and other stakeholders can co-create programs to ensure user experience and delivery is optimized
  • Measure the success of your program with relevant KPIs and ensure continuous feedback to help perfect future support activities

Eli Lilly Canada Andre Cote Chief Operating Officer Eli Lilly Canada

Colontown Meredith Hardy Patient Advocate Colontown

US Pain Foundation inc. Paul Gileno Founder/President US Pain Foundation inc.

FDA Steve Morin Health Programs Coordinator and Director, FDA Patient Network FDA

09:30 - 10:00
Integrating digital to enhance patient support programs: Micro-moments – provide continuous and relevant support throughout the patient journey
  • Understand how to move from an episodic to a continuous patient support model
  • Learn how to understand each individual’s needs across a patient population
  • Integrate behavioral science and provide personalized support specific to each patient’s circumstance

S3 Connected Health Jim O’Donoghue Vice President S3 Connected Health

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Pharma Collaboration’ category from the eyeforpharma Awards

For the first time ever, the winners of the eyeforpharma Awards will be showcasing their winning initiatives. Join this session to:

  • See the very best examples of pharma companies collaborating for a common goal: value to patients and healthcare, using lateral thinking to redefine what’s possible in our industry
  • Identify how you can deliver a new proposition to customers and healthcare systems, creating real innovations, through partnerships

Previous winners include “Moving Mountains for Multiple Myeloma” a partnership between Takeda Oncology, the MMRF and Cure Media.

Talent, Diversity and Reputation
08:30 - 09:00
Panel: Celebrate and nucleate the rock stars of healthcare: How to guarantee talent and diversity
  • Turn your great science, genuine innovation and social mission into a story which appeals to a new generation of incoming talent
  • Identify the future skills and capabilities required by your organization and ensure your recruitment process matches your growing needs
  • Find ways to motivate and satisfy your employees to encourage retention and safeguard the next generation of leaders

Takeda Pharmaceuticals Elena Cant Vice President, Head of Global Commercial, Vaccine Business Unit Takeda Pharmaceuticals

Merck Celeste Warren Vice President, Human Resources and Global Diversity & Inclusion Center of Excellence Merck

Data Capabilities and Analytics
08:30 - 09:00
Unleash the power of data: Optimizing commercial performance though data and analytics
  • Drive competitive advantages through data-driven decision-making based on customer insights and analytics
  • Improve performance of commercial activities through the right metrics, actionable reporting and holistic processes
  • Manage data gaps and data imperfections

Bristol-Myers Squibb Tatiana Simonelli Head of Business Insights & Analytics International Markets Bristol-Myers Squibb

09:00 - 09:30
The power of data to optimize your multichannel strategy
  • Take an innovative approach to measure the success of your MCM, including new measurables to assess the overall impact of your strategy and go beyond individual metrics
  • Benchmark touchpoints along the customer journey, from a combination of channels, which clearly highlight overall performance and red flag areas that need improvement
  • Identify patterns in customer behavior and ensure flexibility in your multichannel model to adapt to new analysis

Bayer Peter Barschdorff Vice President, Business Insights: Innovation Strategy Bayer

External Innovation & Collaboration
08:30 - 09:00
The power of digital Health: Transform opportunity into genuine patient benefit
  • Take advantage of the vast opportunities in digital health by partnering with digital health companies across the healthcare ecosystem
  • Discover what Takeda have learnt from digital health companies, and how they have applied this agile and innovative thinking to their approach
  • Identify where pharma has the greatest opportunity to impact patient’s lives and why must be align as an industry to focus our efforts

Takeda Pharmaceuticals Nicole Mowad Nassar Vice President & Head of U.S. Business Operations & External Partnerships Takeda Pharmaceuticals

09:00 - 09:30
Reach new levels of value: Advancing care in cardiology through partnerships
  • Discover how BMS increased the effective diagnosis of cardio-related diseases through partnerships with governments, payers, data providers and tech
  • Lay the groundwork for effective, long term partnerships and help establish pharma’s role in the larger healthcare ecosystem
  • Navigate reimbursement issues using data and analysis required to prove the value of your services and solutions

Bristol-Myers Squibb Terri Young Worldwide General Manager, Cardiology Bristol-Myers Squibb

09:30 - 10:00
Panel: Is the future of healthcare on your wrist? Optimizing wearables now, not in the future
  • Explore the vast opportunities possible with mobile data recording devises and establish the role wearables can play in your healthcare offering
  • Determine the uses of the real-world data collected and how this data can be effectively analyzed as well as understanding the limitations Prepare for the explosion in wearables and IoT devices and ensure you have a robust strategy which moves past the early adoption stage

Nokia Health Alexis Normand Head of B2B Nokia Health

Samsung Jerard Berger Senior Manager, Healthcare Samsung

Novartis Abhimanyu Verma Global Head – Applied Technology Innovation Novartis

GSK Andrew Ploszay Head, Digital Innovation & Strategic Partnerships GSK

09:30 - 10:00
Leading Innovation: The Digital Medicines
  • Discover how Otsuka and Proteus pioneered an innovative alliance to develop Digital Medicines • Identify best practices when uniting the pharma development and business model with digital technology • Envisage how Otsuka’s new digital medicine might help patients manage their illness and share valuable, objective data with HCPs

Proteus Digital Health David O’Reilly Chief Platform Officer Proteus Digital Health

Otsuka America Pharmaceutical, Inc. Andrew Wright VP, Digital Medicine Otsuka America Pharmaceutical, Inc.

09:30 - 10:00
A detailed overview of the winning initiative in the ‘Most Valuable Pharma Collaboration’ category from the eyeforpharma awards

For the first time ever, the winners of the eyeforpharma Awards will be showcasing their winning initiatives. Join this session to:

  • See the very best examples of pharma companies collaborating for a common goal: value to patients and healthcare, using lateral thinking to redefine what’s possible in our industry
  • Identify how you can deliver a new proposition to customers and healthcare systems, creating real innovations, through partnerships
Sell with Purpose: Kickstart your salesforce
08:30 - 09:00
Build customer relations for the future: Replicate the success of your top performing reps
  • Establish the traits of your top performers with a program that moves middle performers from good to great, and introduces newly relevant skills
  • Define the KPIs needed to measure success in a new climate, and reward positive behaviours which improve long-term customer experience
  • Ensure your reps are upskilled for new digital tools and capabilities

Shire Molly Painter Vice President, Sales, Primary Immunodeficiency and Hereditary Angioedema Shire

09:00 - 09:30
Drive sales through greater alignment of drugs to customer value – and a deeper understanding of the patient journey
  • Discover how top performing reps relate to the patient journey when engaging with HCPs
  • Fully express the value of your products with an improved understanding of life with the illness
  • Explore new ways to train, motivate and incentivize reps which focus on patient needs and meeting customer needs

Roche Diabetes Jay Graves Vice President, Sales Roche Diabetes

09:30 - 10:00
Overcome complexity in the U.S market: A better KAM approach
  • Address the growing complexity of stakeholders with a more sophisticated Key Account Management (KAM) formation, identifying unmet need within healthcare systems
  • Embed new capabilities into account teams (including medical and HEOR) to ensure customer needs can be met
  • Adapt to new methods of engagement, ensuring your reps are well equipped to engage with a new generation of HCPs

Horizon Pharma Paul Lazarro Vice President, Primary Care Sales & Key Accounts Horizon Pharma

Don't miss out - register now

Only 2 days left to save $400 with our Just Launched discount. Don't miss out!